Literature DB >> 6639707

Changes in the density distribution of pig high density lipoproteins during incubation in vitro. Influence of esterified cholesterol transfer activity.

Y C Ha, L Gorjatschko, P J Barter.   

Abstract

Pig plasma, depleted of very low density lipoproteins (VLDL) and low density lipoproteins (LDL) by ultracentrifugation, was incubated in vitro at 37 degrees C in the presence of 0.002 M parachlormercuriphenyl sulfonate, a chemical inhibitor of lecithin: cholesterol acyltransferase. Incubation resulted in a consistent and significant shift in the density distribution of esterified cholesterol within the high density lipoprotein (HDL) fraction. After 24 h of incubation the esterified cholesterol in HDL of density greater than 1.125 g/ml was reduced by a mean of 28%, while that in HDL of density less than 1.125 g/ml was increased by a mean of 77%. Both the rate and the magnitude of this redistribution were markedly enhanced when the incubation mixture contained rabbit lipoprotein-free plasma, a rich source of the esterified cholesterol transfer protein. When pig plasma, depleted of VLDL and LDL, was subjected to rate zonal ultracentrifugation, the HDL in non-incubated samples eluted as a single symmetrical peak in a position comparable to that of human HDL3. After 24 h of incubation at 37 degrees C the density of the HDL was reduced, with a peak midway between the positions of human HDL3 and HDL2. When VLDL- and LDL-depleted pig plasma were mixed with human lipoprotein-free plasma (also a source of esterified cholesterol transfer activity) and incubated for 24 h at 37 degrees C, there was an even greater reduction in the density of pig HDL, which now eluted in a position comparable to that of human HDL2. It was concluded that the capacity of the esterified transfer protein to redistribute esterified cholesterol between different lipoprotein particles may be of importance in the process of HDL interconversion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6639707     DOI: 10.1016/0021-9150(83)90043-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

Review 1.  ATP-binding cassette transporter A1 and HDL metabolism: effects of fatty acids.

Authors:  Jiyoung Lee; Youngki Park; Sung I Koo
Journal:  J Nutr Biochem       Date:  2011-06-17       Impact factor: 6.048

2.  Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.

Authors:  Eric J Niesor; Christine Magg; Naoto Ogawa; Hiroshi Okamoto; Elisabeth von der Mark; Hugues Matile; Georg Schmid; Roger G Clerc; Evelyne Chaput; Denise Blum-Kaelin; Walter Huber; Ralf Thoma; Philippe Pflieger; Makoto Kakutani; Daisuke Takahashi; Gregor Dernick; Cyrille Maugeais
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

Review 3.  Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.

Authors:  Hisashi Shinkai
Journal:  Vasc Health Risk Manag       Date:  2012-05-15

4.  Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys.

Authors:  Mathieu R Brodeur; David Rhainds; Daniel Charpentier; Teodora Mihalache-Avram; Mélanie Mecteau; Geneviève Brand; Evelyne Chaput; Anne Perez; Eric J Niesor; Eric Rhéaume; Cyrille Maugeais; Jean-Claude Tardif
Journal:  J Lipid Res       Date:  2017-05-17       Impact factor: 5.922

5.  Effect of compounds affecting ABCA1 expression and CETP activity on the HDL pathway involved in intestinal absorption of lutein and zeaxanthin.

Authors:  Eric J Niesor; Evelyne Chaput; Jean-Luc Mary; Andreas Staempfli; Andreas Topp; Andrea Stauffer; Haiyan Wang; Alexandre Durrwell
Journal:  Lipids       Date:  2014-10-10       Impact factor: 1.880

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.